14 results for "Sarah Nersesian"
Showing 1–14 · 0.42 seconds · RSS
-
Journal Article
Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
Ovarian cancer (OC) is diagnosed in ~22,000 women in the US each year and kills 14,000 of them. Often, patients are not diagnosed until the later stages of disease, when treatment options are limited, highlighting the urgent need for new and improved therapies for precise cancer control. An…
-
Journal Article
The Tumor Immune Contexture of Prostate Cancer
One in seven men in North America is expected to be diagnosed with prostate cancer (PCa) during their lifetime (1, 2). While a wide range of treatment options including surgery, radiation, androgen deprivation and chemotherapy have been in practice for the last few decades, there are limited…
-
Journal Article
The Journey to a Successful Illustrated Review
Abstract Illustrated review articles, rooted in scientific rigor, are made up of “capsules” or panels of visuals that together provide an up‐to‐date overview of a topic. Illustrated reviews aim to provide a more accessible format than traditional written reviews to facilitate more effective…
-
Journal Article
DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
Abstract Background Molecular subtyping of urothelial cancer (UC) has significantly advanced the understanding of bladder tumor heterogeneity and development of prognostic and predictive biomarkers. Evolving evidence across cancers strongly suggests that tumor immunoediting has a profound impact on…
-
Journal Article
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Natural killer (NK) cells integrate heterogeneous signals for activation and inhibition using germline-encoded receptors. These receptors are stochastically co-expressed, and their concurrent engagement and signaling can adjust the sensitivity of individual cells to putative targets. Against…
-
Journal Article
Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications
Background: Intravesical Bacillus Calmette Guerin (BCG) has been the gold standard immunotherapy to treat high risk non-muscle invasive bladder cancer (NMIBC) for over 40 years. Attenuation of Mycobacterium bovis for clinical use as BCG results in loss of its ability to activate the “Stimulator of…
-
Journal Article
Preparation of mitochondrial damage-associated molecular patterns from mouse liver tissue
Summary: Mitochondrial damage-associated molecular patterns (mitoDAMPs) are released from cells dying uncontrolled, non-apoptotic deaths, usually secondary to disease or trauma. Here, we describe preparation of mitoDAMPs from mouse liver, but this protocol can be adapted for preparation of…
-
Journal Article
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
The immune landscape of a tumor is highly connected to patient prognosis and response to treatment, but little is known about how natural killer (NK) cells predict overall survival (OS) among patients with solid tumors. We present the first meta-analysis on NK cell infiltration into solid tumors as…
-
Journal Article
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
Epithelial ovarian cancer (EOC) is a leading cause of cancer-related death in women. EOC is often diagnosed at late stages, with peritoneal metastases and ascites production. Current surgery and platinum-based chemotherapy regimes fail to prevent recurrence in most patients. High levels of…
-
Journal Article
Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment
IntroductionOvarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and…
-
Journal Article
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages
BackgroundFor patients with high grade serous carcinoma of the ovary (HGSC), survival rates have remained static for the last half century. Despite the presence of tumor mutations and infiltration of immune cells, existing immunotherapies have achieved little success against HGSC. These…
-
Journal Article
Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma
BackgroundPancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers and has limited options for treatment. Low immune infiltration, desmoplastic stroma, and poor tumour immunogenicity are all expected to contribute to PDAC’s rapid progression and limited response to existing…
-
Journal Article
Mitochondrial DNA levels in perfusate and bile during ex vivo normothermic machine correspond with donor liver quality
Ex vivo normothermic machine perfusion (NMP) preserves donor organs and permits real-time assessment of allograft health, but the most effective indicators of graft viability are uncertain. Mitochondrial DNA (mtDNA), released consequent to traumatic cell injury and death, including the…
-
Journal Article
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer
Abstract Breast cancer remains the most prevalent cancer among women, with hormone receptor-positive (HR +) tumors accounting for approximately 70% of breast cancer cases. While the immune checkpoint inhibitor (ICI) anti-programmed cell death 1 (PD-1) pembrolizumab has demonstrated efficacy in…